BAJAJHCARE331.50

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,116 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)198.82192.40257.49257.49
Receivable Days (DSO)138.96169.30139.69139.69
Payable Days (DPO)123.44113.47137.42128.32
Cash Conversion Cycle (days)214.34248.23259.76268.86
Working Capital Turnover15.762.552.452.52
Asset Turnover0.620.650.660.66
Cash Conversion (CFO/Net Income)-1.100.553.683.68
CFO/EBITDA1.210.260.550.55
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.